This group found that SLAMF7 serves as a key receptor promoting the phagocytosis of SLAMF7-expressing hematopoietic tumor cells by macrophages when the inhibitory SIRP-α receptor on macrophages is blocked by antibodies from detecting its ligand, CD47, on the same tumor target cells (36). Here, CD47 is linked to neoplasm.